Trials / Completed
CompletedNCT01021046
Deep Anterior Lamellar Keratoplasty (DALK) Using Acellular Corneal Tissue Promotes Corneal Allograft Survival in High Risk Patients
Deep Anterior Lamellar Keratoplasty Using Acellular Corneal Tissue Promotes Corneal Allograft Survival in High Risk Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 78 (estimated)
- Sponsor
- Wenzhou Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to study whether deep anterior lamellar keratoplasty (DALK) using acellular tissue will promote corneal graft survival in high risk patients.
Conditions
- Glycerin Cryopreserved Acellular Corneal Tissue
- Deep Anterior Lamellar Keratoplasty
- High Risk Keratoplasty
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | DALK using GCCT | Deep anterior lamellar keratoplasty (DALK) using glycerin-cryopreserved corneal tissue |
| PROCEDURE | DALK using FCT | Deep anterior lamellar keratoplasty (DALK) using fresh corneal tissue |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2009-11-26
- Last updated
- 2010-08-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01021046. Inclusion in this directory is not an endorsement.